Navigation Links
Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care
Date:1/20/2009

p>The growing frequency of unrecognized adverse incidents and avoidable patient safety issues resulting in death or serious physical injury is a preventable and costly human tragedy that the Journal of the American Medical Association has reported may account for 2.4 million extra hospital days, over 32,500 deaths, and $9.3 billion in excess charges in the United States annually.(1) These startling statistics have prompted the convergence of leading healthcare accreditation and industry groups toward a common patient safety standard of continuous, noninvasive physiologic monitoring linked to an appropriate clinician alert and notification system for perioperative patients.

The Joint Commission's National Patient Safety Goals call for the "improved recognition and response to changes in a patient's condition" and recommend "a suitable method that enables health care staff members to directly request additional assistance from a specially trained individual(s) when the patient's condition appears to be worsening."(2) The Anesthesia Patient Safety Foundation (APSF) recommendations advise healthcare professionals to "give consideration to the potential safety value of continuous postoperative monitoring of oxygenation and ventilation in at-risk patients without delay," urging that "it is critical that any monitoring system be linked to a reliable process to summon a competent healthcare professional to the patient's bedside in a timely manner."(3) The American Society of Anesthesiologists (ASA) Clinical Practice Guidelines have established that "continuous pulse oximetry monitoring in a step-down unit reduces the likelihood of perioperative complications among patients who are believed to be at increased perioperative risk from OSA."(4)

Masimo Founder and CEO, Joe E. Kiani, stated; "By revolutionizing pulse oximetry with the invention of Signal Extraction Technology (SET), we created a new era where pulse oximeters could measur
'/>"/>

SOURCE Masimo
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
2. Pain medicine meeting unites top researchers and clinicians
3. Does artificial intelligence help clinicians to recognize atrophic gastritis with thyroid disease?
4. Publication Provides a Wake-Up Call For Clinicians Treating Narcolepsy
5. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
6. CME Publication Gives Clinicians a Leg Up in Treating Disorders of the Lower Extremities
7. Streamline Healths Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients Information - Either Scanned or Electronic
8. APCTODAY.com and Convera(R) Launch Vertical Search Site for Advanced Practice Clinicians
9. Report says clinicians should consider economic impact of new interventions
10. AHRQ Releases Two New Resources to Help Consumers and Clinicians Prevent Dangerous Blood Clots
11. Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... New York (PRWEB) June 18, 2013 ... dedicated to protecting the rights of victims injured by ... University’s independent review of Medtronic’s Infuse bone graft products ... Internal Medicine, a medical journal, the two studies serve ... difference in effectiveness” when comparing Infuse and the traditional ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...
(Date:6/18/2013)... shown that cancer cells have a much different ... scientists at The University of Texas at Dallas have ... strategy to combat lung cancer. , In an article ... ONE , UT Dallas researchers compared the metabolic characteristics ... taken from the same patient. , They found ...
(Date:6/18/2013)... More than 1.1 million people in the U.S. ages 13 ... for Disease Control and Prevention (CDC). Of those, nearly 20 ... HIV Testing Day on June 27, Allsup, a nationwide provider ... CDC and other organizations are raising awareness of the importance ... new HIV infections each year. Along with developing AIDS, those ...
(Date:6/18/2013)... Two months ago, Suyima Torres, 28, died from respiratory ... of a silicone treatment for gluteus augmentation at Cuerpos Health ... by a mystery Venezuelan doctor in a center that was ... Vazquez of Bayshore Cosmetic Surgery , women suffering from ... not board certified is more common than people think. ...
Breaking Medicine News(10 mins):Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3
... Defend Intellectual Property RightsINDIANAPOLIS, March 9 Eli Lilly ... the following statement after being granted a temporary restraining ... of Evista(R) (raloxifene HCl tablets) by Teva Pharmaceuticals. Teva ... version prior to the resolution of outstanding patent litigation ...
... Neogen Corporation (Nasdaq: NEOG ) announced ... common stock repurchase program. In December, Neogen,s Board of ... have been, and additional shares are expected to be, ... depending on market conditions and other factors. Accordingly, there ...
... renders melanomas sensitive to retinoic acid and stops tumor ... cancer therapies such as radiotherapy, chemotherapy, and retinoic acid ... the prognosis for patients is often poor. However, Vincent ... the National Institutes of Health in Bethesda, Maryland, have ...
... Akerman Senterfitt today announced that Julie Gallagher has joined ... Healthcare Practice Group. Ms. Gallagher,s work focuses on ... companies, individual health care providers and health care facilities. ... she spent seven years as a shareholder."We are very ...
... to Announce Fiscal Third Quarter Results on ... Allscripts-Misys Healthcare Solutions, Inc. ("Allscripts") announced today ... to sell its Medication Services business to ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO )The transaction, which is anticipated ...
... Inc. (Nasdaq: KERX ) today announced that ... Listings Qualification Panel ("Panel") the determination of The Nasdaq ... The Nasdaq Capital Market due to noncompliance with Nasdaq ... a minimum of $2,500,000 in stockholders, equity, or $35,000,000 ...
Cached Medicine News:Health News:Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene 2Health News:Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene 3Health News:Neogen Reactivates Share Repurchase Program 2Health News:JCI online early table of contents: March 9, 2009 2Health News:JCI online early table of contents: March 9, 2009 3Health News:JCI online early table of contents: March 9, 2009 4Health News:JCI online early table of contents: March 9, 2009 5Health News:Julie Gallagher Joins Akerman Senterfitt's Healthcare Practice 2Health News:Allscripts to Sell Its Medication Services Business to A-S Medication Solutions, Sign Joint Marketing Agreement 2Health News:Allscripts to Sell Its Medication Services Business to A-S Medication Solutions, Sign Joint Marketing Agreement 3Health News:Allscripts to Sell Its Medication Services Business to A-S Medication Solutions, Sign Joint Marketing Agreement 4Health News:Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq 2Health News:Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq 3
(Date:6/18/2013)... 18, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... announced today that VPII Escrow Corp., a newly formed ... its offer of approximately $3.2 billion aggregate principal amount ... be due in 2021 and in 2023, with final ... to use the net proceeds from the offering, together ...
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...
(Date:6/18/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: ... announced public offering of common shares (the "Offering"). Pursuant ... shares at a price of $85.00 per share, for ... will file a final prospectus supplement to its effective ... a similar filing with the securities regulatory authorities in ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
... Sept. 16 Boston Scientific Corporation (NYSE: ... Drug Administration (FDA) has approved an expanded indication for ... CRT-D.  The exclusive expanded indication is effective immediately and ... the FDA for patients in all New York Heart ...
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ... and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory ... do not adequately demonstrate that the potential benefits of ... a population of overweight and obese individuals to allow ...
Cached Medicine Technology:Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 2Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 3Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 4Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 2Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 3Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: